Wenfeng Li

714 total citations
20 papers, 531 citations indexed

About

Wenfeng Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wenfeng Li has authored 20 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Wenfeng Li's work include Pediatric Urology and Nephrology Studies (4 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Ureteral procedures and complications (3 papers). Wenfeng Li is often cited by papers focused on Pediatric Urology and Nephrology Studies (4 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Ureteral procedures and complications (3 papers). Wenfeng Li collaborates with scholars based in China, United States and Pakistan. Wenfeng Li's co-authors include Zhong Wang, Jie Wu, Minjiang Chen, Pengfei Ma, Jing Wang, Mei‐Chun Cai, Zhuang Yu, Haijiao Lu, Shengzhe Zhang and Xiaojing Zhao and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and FEBS Letters.

In The Last Decade

Wenfeng Li

19 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenfeng Li China 10 394 113 94 85 65 20 531
Shidong Xu China 7 328 0.8× 196 1.7× 48 0.5× 92 1.1× 63 1.0× 9 546
Hanan Long China 7 276 0.7× 44 0.4× 73 0.8× 50 0.6× 42 0.6× 13 384
Wenjing Zai China 16 350 0.9× 56 0.5× 116 1.2× 35 0.4× 72 1.1× 26 712
Yuan Liang China 13 281 0.7× 104 0.9× 52 0.6× 50 0.6× 65 1.0× 22 539
Hongping Wang China 13 251 0.6× 106 0.9× 97 1.0× 37 0.4× 51 0.8× 43 517
Zhiru Xiu China 10 246 0.6× 72 0.6× 51 0.5× 71 0.8× 32 0.5× 17 358
Lixia Bai China 13 279 0.7× 71 0.6× 67 0.7× 41 0.5× 100 1.5× 28 538
Lei Yan China 11 176 0.4× 85 0.8× 62 0.7× 113 1.3× 73 1.1× 57 423
Rajesh Kumar Dutta United States 14 271 0.7× 91 0.8× 81 0.9× 78 0.9× 37 0.6× 21 616

Countries citing papers authored by Wenfeng Li

Since Specialization
Citations

This map shows the geographic impact of Wenfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Li more than expected).

Fields of papers citing papers by Wenfeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Li. The network helps show where Wenfeng Li may publish in the future.

Co-authorship network of co-authors of Wenfeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Li. A scholar is included among the top collaborators of Wenfeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Li. Wenfeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wen‐Bin, Yutao Zhan, Wenfeng Li, et al.. (2024). Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors. Journal of Nanobiotechnology. 22(1). 761–761. 1 indexed citations
2.
Li, Wenfeng, Abbas Khan, Dong‐Qing Wei, et al.. (2023). Inhibition of cMYC-MAX transcription factors hetero-dimerization with structurally engineered omoMYC to downregulate oncogenic pathways in renal carcinoma. Computers in Biology and Medicine. 164. 107257–107257. 3 indexed citations
3.
4.
Li, Wenfeng, et al.. (2022). Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways. Pharmaceutical Biology. 60(1). 1865–1875. 8 indexed citations
5.
6.
Li, Wenfeng, Hua Bao, Xin Gu, et al.. (2022). METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling. Cell Transplantation. 31. 4221180853–4221180853. 26 indexed citations
7.
Hu, Nan, Yao Fu, Wenfeng Li, et al.. (2021). Chemical mitochondrial uncouplers share common inhibitory effect on NLRP3 inflammasome activation through inhibiting NFκB nuclear translocation. Toxicology and Applied Pharmacology. 414. 115426–115426. 14 indexed citations
8.
Li, Wenfeng, Xin Gu, Qi Chen, et al.. (2021). Circular RNA_PDHX Promotes the Proliferation and Invasion of Prostate Cancer by Sponging MiR-378a-3p. Frontiers in Cell and Developmental Biology. 8. 602707–602707. 19 indexed citations
9.
Wang, Yiwei, Mingxi Xu, Wenfeng Li, et al.. (2021). A novel spherical-headed fascial dilator is feasible for second-stage ultrasound guided percutaneous nephrolithotomy: A pilot study. Asian journal of urology. 8(4). 424–429. 1 indexed citations
10.
11.
Li, Wenfeng, et al.. (2021). Is 10/12 Fr Ureteral Access Sheath more Suitable for Flexible Ureteroscopic Lithotripsy?. PubMed. 19(2). 89–94. 3 indexed citations
12.
Li, Wenfeng, Xin Gu, Qi Chen, et al.. (2020). Silencing of ELK3 Induces S‐M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells. BioMed Research International. 2020(1). 2406159–2406159. 17 indexed citations
13.
Da, Jun, Mingxi Xu, Yiwei Wang, et al.. (2019). Kaempferol Promotes Apoptosis While Inhibiting Cell Proliferation via Androgen-Dependent Pathway and Suppressing Vasculogenic Mimicry and Invasion in Prostate Cancer. Analytical Cellular Pathology. 2019. 1–10. 62 indexed citations
14.
Wang, Yiwei, et al.. (2019). It is efficient to monitor the status of implanted ureteral stent using a mobile social networking service application. Urolithiasis. 48(1). 79–84. 6 indexed citations
15.
Lu, Haijiao, Shengzhe Zhang, Jie Wu, et al.. (2018). Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death. Clinical Cancer Research. 24(23). 6066–6077. 204 indexed citations
16.
Bao, Hua, Wenfeng Li, Haijun Yao, et al.. (2018). [Surgical repair of the tunica albuginea for penis fracture: Selection of incision].. PubMed. 24(4). 331–334. 2 indexed citations
17.
Zhang, Lu, Ye Wang, Wenfeng Li, et al.. (2017). MicroRNA-30a Regulation of Epithelial-Mesenchymal Transition in Diabetic Cataracts Through Targeting SNAI1. Scientific Reports. 7(1). 1117–1117. 43 indexed citations
18.
19.
Chen, Xiaolan, et al.. (2008). Synthesis of Phosphoryl Amino Acids Chrysin Esters. Phosphorus, sulfur, and silicon and the related elements. 183(2-3). 603–609. 6 indexed citations
20.
Jin, Wei, Gen‐Hong Di, Junjie Li, et al.. (2007). Expression of Concern: TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade. FEBS Letters. 581(20). 3826–3832. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shidong Xu Breakdown of academic impact, for papers by Hanan Long Breakdown of academic impact, for papers by Wenjing Zai Breakdown of academic impact, for papers by Yuan Liang Breakdown of academic impact, for papers by Hongping Wang Breakdown of academic impact, for papers by Zhiru Xiu Breakdown of academic impact, for papers by Lixia Bai Breakdown of academic impact, for papers by Lei Yan Breakdown of academic impact, for papers by Rajesh Kumar Dutta
Rankless by CCL
2026